A woman known as the "Ketamine Queen" has been sentenced to 15 years in federal prison for selling the ketamine that killed beloved "Friends" star Matthew Perry in October 2023, marking a significant conclusion to one of the most high-profile celebrity overdose cases in recent memory.
US District Judge Sherilyn Peace Garnett handed down the sentence Wednesday to 42-year-old Jasveen Sangha, a British-American drug dealer who had boasted about supplying an elite circle of Hollywood VIPs with dangerous substances. Sangha became the third defendant sentenced among five people who pleaded guilty in connection with Perry's fatal overdose.
The Case Against the "Ketamine Queen"
Sangha, who has been in federal custody since 2024, pleaded guilty last year to a series of charges including distribution of ketamine resulting in death or serious bodily harm. Federal prosecutors described her operation as sophisticated and far-reaching, targeting wealthy clients in Hollywood and beyond.
The investigation revealed that Sangha operated what authorities called a "drug-selling emporium" from her North Hollywood residence, where she maintained a substantial inventory of ketamine, methamphetamine, cocaine, and Xanax. Text messages and other evidence showed she specifically marketed her services to high-profile clientele, often referring to her ketamine as "Dr. Pepper" in coded communications.
"She knew the ketamine she sold killed Matthew Perry, but she continued to sell to others."
— Federal Prosecutor, Department of Justice
Matthew Perry's Tragic Final Days
Matthew Perry, best known for his role as Chandler Bing on the iconic NBC sitcom "Friends," died on October 28, 2023, at his Pacific Palisades home at age 54. The Los Angeles County Medical Examiner determined that Perry died from the "acute effects of ketamine" and subsequent drowning after being found unresponsive in his hot tub.
Perry had been receiving legitimate ketamine therapy for depression and anxiety, but the levels found in his system at the time of his death were far higher than what would be expected from medical treatment. The autopsy revealed ketamine levels consistent with those used during general anesthesia.
The beloved actor had been open about his struggles with addiction throughout his career, having spent years battling dependencies on prescription drugs and alcohol. Despite multiple attempts at rehabilitation, Perry continued to struggle with substance abuse issues that ultimately contributed to his untimely death.
The Drug Distribution Network
The investigation into Perry's death uncovered a complex network of individuals who facilitated the illegal drug transactions. Sangha was identified as the primary supplier, working through intermediaries including Perry's personal assistant Kenneth Iwamasa and acquaintance Erik Fleming.
Court documents revealed that in the weeks leading up to Perry's death, the network supplied him with approximately 20 vials of ketamine in exchange for $11,000 in cash. The transactions were conducted with full knowledge that Perry was struggling with addiction and posed a significant risk for overdose.
Federal investigators also discovered that Sangha continued selling ketamine to other clients even after learning of Perry's death, demonstrating what prosecutors described as "callous disregard for human life." Search warrants executed at her residence yielded substantial quantities of illegal drugs, scales, packaging materials, and more than $10,000 in cash.
Legal Proceedings and Sentencing
During Wednesday's sentencing hearing, Judge Garnett emphasized the severity of Sangha's crimes and their impact on both Perry's family and the broader community. The 15-year sentence reflects federal guidelines for drug distribution resulting in death, sending a strong message about accountability in celebrity overdose cases.
Two other defendants have already been sentenced in the case. Dr. Mark Chavez, who illegally supplied ketamine to the distribution network, received eight months of home confinement after pleading guilty to conspiracy charges. Kenneth Iwamasa, Perry's live-in personal assistant who administered the fatal injection, was sentenced to several months in federal prison.
Two additional defendants, including another physician, are expected to face sentencing in the coming months as the legal proceedings continue to unfold.
Impact on Celebrity Drug Culture
The case has highlighted the dangerous intersection of celebrity culture and illegal drug distribution networks that specifically target high-profile individuals. Law enforcement officials note that Sangha's operation exemplified how dealers exploit the wealth and vulnerability of celebrities struggling with addiction.
Federal authorities have indicated that the Perry case represents part of a broader crackdown on illegal ketamine distribution, particularly targeting suppliers who market to wealthy clientele in Los Angeles and other entertainment centers.
"This sentence should serve as a warning to anyone who thinks they can profit from the addiction and desperation of others, especially those in the public eye."
— DEA Special Agent in Charge
Perry's Legacy and Ongoing Investigation
Matthew Perry's death sent shockwaves through the entertainment industry and among the millions of fans who grew up watching "Friends." His co-stars and colleagues remembered him as a talented comedian who brought joy to audiences while privately battling serious personal demons.
The actor had been working on various projects at the time of his death, including advocacy for addiction recovery programs. His struggles with substance abuse were well-documented in his 2022 memoir, where he candidly discussed his journey through addiction and recovery.
The investigation into Perry's death has also prompted renewed scrutiny of how ketamine is prescribed and monitored in clinical settings. While the drug has legitimate medical uses for treating depression and chronic pain, authorities are examining whether additional safeguards are needed to prevent diversion to illegal markets.
Broader Implications for Drug Enforcement
The successful prosecution in the Perry case demonstrates federal law enforcement's commitment to pursuing high-level drug distributors who target vulnerable populations. The case involved extensive cooperation between multiple agencies, including the DEA, FBI, and Los Angeles Police Department.
Legal experts note that the 15-year sentence for Sangha is significant in the context of federal drug cases, reflecting both the severity of the charges and the high-profile nature of the victim. The sentence serves as a deterrent to others who might consider similar operations targeting celebrities or other wealthy clients.
The case has also sparked discussions about the need for enhanced monitoring of ketamine distribution, both in clinical settings and through illegal channels. Authorities are working to develop better tracking systems to prevent legitimate ketamine from being diverted to illegal markets.
Moving Forward
As the legal proceedings continue for the remaining defendants, Perry's family and friends continue to advocate for addiction awareness and treatment resources. The case serves as a stark reminder of the ongoing opioid and synthetic drug crisis affecting communities across the United States.
The sentencing of Jasveen Sangha marks a crucial step toward justice for Matthew Perry's death while highlighting the deadly consequences of illegal drug distribution networks that prey on vulnerable individuals struggling with addiction.
Federal authorities have indicated that investigations into similar networks continue, with additional prosecutions expected as law enforcement agencies work to dismantle the illegal drug distribution systems that contributed to Perry's tragic death and continue to threaten public safety.